Tirzepatide
Tirzepatide, synthetic GIP/GLP-1 receptor dual agonist peptide
- SKU family:
- TR
- CAS:
- 2023788-19-2
- Format:
- Lyophilised powder, sealed glass vial
Synthetic dual-agonist peptide supplied as lyophilised powder in a sealed vial for laboratory research.
$37.00
Availability pending
1
Research use only. For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use, diagnostic use, or any form of administration.
No published batch record for this material yet.
Overview
Tirzepatide is a synthetic peptide described in the literature as a dual GIP and GLP-1 receptor agonist. Supplied as lyophilised powder with the nominal fill stated on the vial label and in the batch record.
Research
Single-chain synthetic peptide bearing a C20 fatty diacid moiety. Reported molecular characteristics are drawn from published chemistry literature, not from Batch One measurements, unless a batch report states otherwise.
Incretin receptor agonists: a research overview
How GIP, GLP-1, and glucagon receptor agonist peptides are characterised in the published literature, and what the evidence base does and does not establish.
Last reviewed 2026-08-14 · Research content reviewer, Batch One
Documentation
No published batch record exists for this material yet. We do not state identity, purity, mass, sterility, or endotoxin status without a report for the exact lot.
FAQ
Related materials
Tirzepatide · 5 mg
$37.00